About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Amyloidosis Cardiomyopathy: Strategies for Early Diagnosis and Treatment
By
24th Annual Heart Failure 2020: an Update on Therapy
FEATURING
Matthew Maurer
By
24th Annual Heart Failure 2020: an Update on Therapy
FEATURING
Matthew Maurer
47 views
August 27, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
12:30
Houston Methodist Hospital
Amyloidosis Types and Pathophysiology
Feat.
B. Trachtenberg
15:38
CCM® Therapy
THT 2024: CCM® Therapy - Don’t Wait!
Feat.
R. Kahwash
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
18:34
Houston Methodist DeBakey Heart and Vascular Center
ECG Interpretation: Everything You Need to Know to Understand and In…
Feat.
A. Dave
16:45
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Amyloidosis - Update and How To Use Novel Agents
Feat.
S. Lentzsch
10:09
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium
Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF
35:16
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
Feat.
M. Kittleson
09:47
CCM® Therapy
THT 2024: Heart Failure Management Today – GDMT, CRT, and CCM® Thera…
Feat.
J. Butler
12:28
CCM® Therapy
THT 2024: Update on the Integra-D Trial - CCM® Therapy
Feat.
N. Varma
17:29
UCLA Health
Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics
Feat.
D. Vucicevic
54:48
CCM® Therapy
THT 2024: CCM® Therapy in Addition to GDMT: Optimizing Strategy fo…
Feat.
R. Kahwash,
N. Varma,
J. Singh,
N. Albert,
J. Butler
59:18
CCM® Therapy
CCM® Around the World — How One Device-based Heart Failure Intervent…
Feat.
K. Ellenbogen,
J. Kuschyk,
N. Varma,
I. Whitman,
J. Singh
20:59
Mary E. Money
Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…
37:36
Michigan Medicine
Implementation of Drug Therapies for Heart Failure with Reduced Ejec…
Feat.
J. Golbus
16:48
Vaishnavi Kundel
ATS 2023 Insights: To PAP or Not to PAP - Heart Failure and Sleep Di…
Feat.
V. Kundel
24:57
24th Annual Heart Failure 2020: an Update on Therapy
50th Anniversary of the Swan-Ganz Catheter: Development of the Swan-…
Feat.
J. Forrester
16:00
24th Annual Heart Failure 2020: an Update on Therapy
COVID-19 and Heart Failure
Feat.
M. Mehra
20:10
ACC 2024 Insights
ACC 2024 Insights: PVC Burden and Its Temporal Variability - 24/48 H…
Feat.
J. Cheung
09:00
Cecilia Bahit
The Best of AHA23 for the Primary Care Doctor
60:13
CVRx | Barostim
Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients
Feat.
G. Panjrath,
C. Economides,
J. Jefferies
